Skip to content
HowShorted

Bionano Genomics, Inc. short interest in 2023

In 2023, Bionano Genomics, Inc.'s disclosed short interest ran from 17.93% of shares outstanding on 13 Jan 2023 to 13.02% on 29 Dec 2023, a change of -4.91 percentage points. The year's high was 21.03% on 15 May 2023 and its low 13.02% on 29 Dec 2023, averaging 17.44% across 18 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 14.03 days on 31 Mar 2023. Full history: Bionano Genomics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Bionano Genomics, Inc. in 2023

2023 in figures

Start of year
17.93% (13 Jan 2023)
End of year
13.02% (29 Dec 2023)
Change
-4.91 pp
High
21.03% (15 May 2023)
Low
13.02% (29 Dec 2023)
Average
17.44%
Highest days to cover
14.03 (31 Mar 2023)
SEC filings marked
12

Every report in 2023

Bionano Genomics, Inc. short interest in 2023
SettlementShort interestDays to coverFilings since previous
13 Jan 202317.93%7.80results (8-K)
31 Jan 202317.60%8.23
15 Feb 202316.57%6.97results (8-K)
28 Feb 202319.42%7.62
15 Mar 202317.89%8.4610-K filed, results (8-K)
31 Mar 202319.03%14.03
14 Apr 202320.54%13.33
28 Apr 202320.33%4.46results (8-K)
15 May 202321.03%8.5410-Q filed, results (8-K)
31 May 202320.45%6.90
15 Jun 202319.53%5.98
30 Jun 202315.71%3.52
14 Jul 202314.34%3.79
31 Jul 202314.77%5.13
15 Nov 202318.23%5.5710-Q filed, results (8-K), results (8-K), 10-Q filed, results (8-K)
30 Nov 202314.27%4.36
15 Dec 202313.23%3.28
29 Dec 202313.02%1.87

See also: Bionano Genomics, Inc.'s full history · most shorted US stocks of 2023 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.